Since the adjuvant effects of IL-7 in enhancing cancer vaccine-induced T-cell responses have recently been demonstrated35,36, we posit that the IL-7Rα+ polyfunctional CD4+ effector cells arising after ACT would be amenable to adjuvant IL-7. Here, CD4 is linked to cancer.